#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia A without inhibitors Follicular lymphoma stage I Hypomagnesaemia Malformation venous Duchenne muscular dystrophy gene carrier Osteochondrodysplasia Fallopian tube cancer Carcinoid tumour Advanced systemic mastocytosis IPEX syndrome Antiphospholipid syndrome Chronic granulomatous disease Hyperinsulinism Neuroendocrine tumour Myeloproliferative neoplasm More trials…

    Learn about Rare Diseases

    Biotinidase deficiency – Treatment Systemic mastocytosis – Life with Disease Stevens-Johnson syndrome – Diagnostics Factor IX deficiency – Diagnostics Pleomorphic leiomyosarcoma – Diagnostics Angiosarcoma recurrent – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS Uterine leiomyosarcoma – Life with Disease Rosai-Dorfman syndrome – Diagnostics Pulmonary sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Testosterone Undecanoate AZD3632 ANOC-001 Soya Oil, Purified Dalbavancin Alpha-Tocopherol Cln-081 Camizestrant Tapderimotide Rivaroxaban Doxazosin Mesilate Bilastine Elvn-002-1 Elritercept 2,4 DICHLOROBENZYL ALCOHOL Autologous Chondrocytes NALDEMEDINE Abt-494 Nirmatrelvir Inebilizumab More therapies…

    Learn about Your Condition

    Chronic kidney disease Tachypnoea Petit mal epilepsy SAPHO syndrome Stress Diabetic foot Cerebral palsy Pulmonary embolism Right ventricular dysfunction Periarthritis Anaemia of pregnancy Choroidal neovascularisation Dilated cardiomyopathy Type 2 diabetes mellitus Frontotemporal dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Methylprednisolone Acetate
    • Paracetamol
    Sweden

  • Study on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Dexamfetamine Sulfate
    Norway

  • Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mrna-4157
    • Pembrolizumab
    Belgium Czechia Denmark Estonia Finland France +12

  • Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Darunavir
    • Dolutegravir Sodium
    • Lamivudine
    France

  • Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Trabectedin
    • Dostarlimab
    • Ifosfamide
    France

  • Study on Sufentanil’s Effect on Chronic Pain After Non-Major Abdominal Surgery for Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sufentanil
    France
Previous Page
1 … 453 454 455 456 457 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!